Short-Term Outcomes of Pediatric Patients With Mild Autosomal Recessive <i>RPE65</i>-Associated Retinal Dystrophy Treated With Voretigene Neparvovec

This study aids clinical decision-making in unclear cases by demonstrating that early treatment with voretigene neparvovec in mild RPE65-IRD provides functional benefits while minimizing the risk of fast-growing chorioretinal atrophy.

Authors

Institutions

Publication Details

Journal
Translational Vision Science & Technology
Published
2025-08-04
DOI
https://doi.org/10.1167/tvst.14.8.8
Citations
2
Primary Topic
Retinal Development and Disorders
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-Term Outcomes of Pediatric Patients With Mild Autosomal Recessive RPE65-Associated Retinal Dystrophy Treated With Voretigene Neparvovec

Lasse Wolfram, Tobias B. Haack, Susanne Kohl, Bart P. Leroy et al.
2 citations
Translational Vision Science & Technology
Retinal Development and Disorders
1.61
article

Short-Term Outcomes of Pediatric Patients With Mild Autosomal Recessive RPE65-Associated Retinal Dystrophy Treated With Voretigene Neparvovec

Lasse Wolfram, Tobias B. Haack, Susanne Kohl, Bart P. Leroy, Klaus Rüther, Fanny Nerinckx, Laura Kuehlewein, Pascale Mazzola, David A. Merle, Cord Huchzermeyer, Katarína Štingl, Melanie Kempf, Elfride De Baere, Marieke De Bruyne, Spyridon Dimopoulos, Barbara Janssens, Krunoslav Stingl, Manon van Haute, Leen Hertens
article en
2 citations

Abstract

This study aids clinical decision-making in unclear cases by demonstrating that early treatment with voretigene neparvovec in mild RPE65-IRD provides functional benefits while minimizing the risk of fast-growing chorioretinal atrophy.

Translational Vision Science & TechnologyVol. 14(8)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Medical University of Graz (AT), Berlin Zoological Garden (DE), Ghent University Hospital (BE), Ghent University (BE), Universitätsklinikum Erlangen (DE), Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE), STZ eyetrial (DE), University of Tübingen (DE)
Biogen, REGENXBIO, Eberhard Karls Universität Tübingen, Fonds Wetenschappelijk Onderzoek, Universitair Ziekenhuis Gent, Santen, Universiteit Gent, Vlaamse regering, H. Lundbeck A/S, ProQR Therapeutics, Spark Therapeutics, Janssen Pharmaceuticals
Zero hunger
Openalex Percentile: Top 16%
Retinal Development and Disorders
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.